Evidence map›Paper›PMID 31010447›Full record

ArticlePsychological medicine2020

Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change.

Tory A Eisenlohr-Moul, Gudrun Kaiser, Cornelia Weise, Katja M Schmalenberger, Jeff Kiesner, Beate Ditzen, Maria Kleinstäuber

Open access · greenAbstract read
In one paragraph

Article in Psychological medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Biomarker development for menstrual cycle affective change: the need for greater temporal, mechanistic, and phenotypic specificity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  18. Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Tory A Eisenlohr-MoulDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
Gudrun KaiserUniversity of Marburg, Marburg, Germany.
Cornelia WeiseUniversity of Marburg, Marburg, Germany.
Katja M SchmalenbergerHeidelberg University, Heidelberg, Germany.
Jeff KiesnerUniversità degli Studi di Padova, Padova, Italy.
Beate DitzenHeidelberg University, Heidelberg, Germany.
Maria KleinstäuberUniversity of Otago, Dunedin, New Zealand.
Heidelberg University · DEPhilipps University of Marburg · DEUniversity of Illinois Chicago · USUniversity of Otago · NZUniversity of Padua · IT

Funding

Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental ApproachRF1MH120843 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI EISENLOHR-MOUL, TORY ANNE · 2019 to 2019
$3.1M
Postdoctoral Training in Reproductive Mood DisordersT32MH093315 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN Scott GIRDLER, David R. Rubinow · 2012 to 2026
$2.8M
Ovarian Hormone Withdrawal and Suicide Risk: An Experimental ApproachR00MH109667 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI EISENLOHR-MOUL, TORY ANNE · 2018 to 2020
$747k
NIMH NIH HHS R00 MH109667NIMH NIH HHS RF1 MH120843NIMH NIH HHS T32 MH093315
6 · The paper itself

Abstract

backgroundPremenstrual dysphoric disorder (PMDD) is a new Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis characterized by the cyclical emergence of emotional and physical symptoms in the luteal phase of the menstrual cycle, with symptom remission in the follicular phase. Converging evidence highlights the possibility of distinct subtypes of PMDD with unique pathophysiologies, but temporal subgroups have yet to be explored in a systematic way.

methodsIn the current work, we use group-based trajectory modeling to identify unique trajectory subgroups of core emotional and total PMDD symptoms across the perimenstrual frame (days -14 to +9, where day 0 is menstrual onset) in a sample of 74 individuals prospectively diagnosed with DSM-5 PMDD.

resultsFor the total daily symptom score, the best-fitting model was comprised of three groups: a group demonstrating moderate symptoms only in the premenstrual week (65%), a group demonstrating severe symptoms across the full 2 weeks of the luteal phase (17.5%), and a group demonstrating severe symptoms in the premenstrual week that were slow to resolve in the follicular phase (17.5%).

conclusionsThese trajectory groups are discussed in the context of the latest work on the pathophysiology of PMDD. Experimental work is needed to test for the presence of possible pathophysiologic differences in trajectory groups, and whether unique treatment approaches are needed.

Indexed as

AdultEmotionsFemaleFollicular PhaseHumansIndividualityLuteal PhaseMenstrual CyclePremenstrual Dysphoric DisorderSurveys and QuestionnairesYoung AdultGroup-based trajectory modelingmenstrual cyclepremenstrual dysphoric disorderpremenstrual syndrome

Identifiers

PMID31010447
PMCPMC8168625
OpenAlexW2941181943

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.